Predictors of the post-thrombotic syndrome and their effect on the therapeutic management of deep vein thrombosis

Journal of Vascular Surgery: Venous and Lymphatic Disorders

Volumn 4, Issue 4, 2016, Pages 531-534

  Galanaud, Jean Philippe ^a   Monreal, Manuel ^b   Kahn, Susan R ^c  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; C REACTIVE PROTEIN; D DIMER; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LOW MOLECULAR WEIGHT HEPARIN;

AGE DISTRIBUTION; AGING; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DRUG EFFICACY; FIBRINOLYSIS; HUMAN; INFLAMMATION; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; OBESITY; PATIENT MONITORING; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; RISK FACTOR; TREATMENT DURATION; VEIN INSUFFICIENCY; VEIN OCCLUSION; COMPLICATION; VEIN THROMBOSIS;

HUMANS; POSTTHROMBOTIC SYNDROME; RISK FACTORS; VENOUS INSUFFICIENCY; VENOUS THROMBOSIS;

EID: 84953255965     PISSN: 2213333X     EISSN: 22133348     Source Type: Journal    
DOI: 10.1016/j.jvsv.2015.08.005     Document Type: Article

References (31)

1. 1 Galanaud, J.P., Kahn, S.R., Postthrombotic syndrome: a 2014 update. Curr Opin Cardiol 29 (2014), 514–519.
2. 2 Kahn, S.R., How I treat postthrombotic syndrome. Blood 114 (2009), 4624–4631.
3. 3 Kahn, S.R., Partsch, H., Vedantham, S., Prandoni, P., Kearon, C., Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. J Thromb Haemost 7 (2009), 879–883.
4. 4 Galanaud, J.P., Kahn, S.R., The post-thrombotic syndrome: a 2012 therapeutic update. Curr Treat Options Cardiovasc Med 15 (2013), 153–163.
5. 5 Kahn, S.R., Comerota, A.J., Cushman, M., Evans, N.S., Ginsberg, J.S., Goldenberg, N.A., et al. The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation 130 (2014), 1636–1661.
6. 6 Kearon, C., Akl, E.A., Comerota, A.J., Prandoni, P., Bounameaux, H., Goldhaber, S.Z., et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141 (2012), e419S–e494S.
7. 7 Kahn, S.R., Shrier, I., Julian, J.A., Ducruet, T., Arsenault, L., Miron, M.J., et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 149 (2008), 698–707.
8. 8 Stain, M., Schonauer, V., Minar, E., Bialonczyk, C., Hirschl, M., Weltermann, A., et al. The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease. J Thromb Haemost 3 (2005), 2671–2676.
9. 9 Tick, L.W., Kramer, M.H., Rosendaal, F.R., Faber, W.R., Doggen, C.J., Risk factors for post-thrombotic syndrome in patients with a first deep venous thrombosis. J Thromb Haemost 6 (2008), 2075–2081.
10. 10 Asbeutah, A.M., Riha, A.Z., Cameron, J.D., McGrath, B.P., Five-year outcome study of deep vein thrombosis in the lower limbs. J Vasc Surg 40 (2004), 1184–1189.
11. 11 Monreal, M., Martorell, A., Callejas, J.M., Valls, R., Llamazares, J.F., Lafoz, E., et al. Venographic assessment of deep vein thrombosis and risk of developing post-thrombotic syndrome: a prospective study. J Intern Med 233 (1993), 233–238.
12. 12 Delis, K.T., Bountouroglou, D., Mansfield, A.O., Venous claudication in iliofemoral thrombosis: long-term effects on venous hemodynamics, clinical status, and quality of life. Ann Surg 239 (2004), 118–126.
13. 13 Bouman, A.C., Cheung, Y.W., Spronk, H.M., Schalkwijk, C.G., ten Cate, H., ten Wolde, M., et al. Biomarkers for post thrombotic syndrome: a case-control study. Thromb Res 134 (2014), 369–375.
14. 14 van Dongen, C.J., Prandoni, P., Frulla, M., Marchiori, A., Prins, M.H., Hutten, B.A., Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome. J Thromb Haemost 3 (2005), 939–942.
15. 15 Labropoulos, N., Jen, J., Jen, H., Gasparis, A.P., Tassiopoulos, A.K., Recurrent deep vein thrombosis: long-term incidence and natural history. Ann Surg 251 (2010), 749–753.
16. 16 Prandoni, P., Lensing, A.W., Cogo, A., Cuppini, S., Villalta, S., Carta, M., et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 125 (1996), 1–7.
17. 17 Prandoni, P., Lensing, A.W., Prins, M.H., Frulla, M., Marchiori, A., Bernardi, E., et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med 141 (2004), 249–256.
18. 18 Galanaud, J.P., Holcroft, C.A., Rodger, M.A., Kovacs, M.J., Betancourt, M.T., Wells, P.S., et al. Comparison of the Villalta post-thrombotic syndrome score in the ipsilateral vs. contralateral leg after a first unprovoked deep vein thrombosis. J Thromb Haemost 10 (2012), 1036–1042.
19. 19 Galanaud, J.P., Holcroft, C.A., Rodger, M.A., Kovacs, M.J., Betancourt, M.T., Wells, P.S., et al. Predictors of post-thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency. J Thromb Haemost 11 (2013), 474–480.
20. 20 Kahn, S.R., Shapiro, S., Wells, P.S., Rodger, M.A., Kovacs, M.J., Anderson, D.R., et al. Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial. Lancet 383 (2014), 880–888.
21. 21 Eberhardt, R.T., Raffetto, J.D., Chronic venous insufficiency. Circulation 130 (2014), 333–346.
22. 22 Kahn, S.R., Shrier, I., Shapiro, S., Houweling, A.H., Hirsch, A.M., Reid, R.D., et al. Six-month exercise training program to treat post-thrombotic syndrome: a randomized controlled two-centre trial. CMAJ 183 (2011), 37–44.
23. 23 Sartori, M., Favaretto, E., Cini, M., Legnani, C., Palareti, G., Cosmi, B., D-dimer, FVIII and thrombotic burden in the acute phase of deep vein thrombosis in relation to the risk of post-thrombotic syndrome. Thromb Res 134 (2014), 320–325.
24. 24 Schulman, S., Lindmarker, P., Holmstrom, M., Lärfars, G., Carlsson, A., Nicol, P., et al. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost 4 (2006), 734–742.
25. 25 Bauer, G., Thrombosis; early diagnosis and abortive treatment with heparin. Lancet 1 (1946), 447–454.
26. 26 Hull, R.D., Liang, J., Townshend, G., Long-term low-molecular-weight heparin and the post-thrombotic syndrome: a systematic review. Am J Med 124 (2011), 756–765.
27. 27 Chitsike, R.S., Rodger, M.A., Kovacs, M.J., Betancourt, M.T., Wells, P.S., Anderson, D.R., et al. Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study. J Thromb Haemost 10 (2012), 2039–2044.
28. 28 Lang, K.J., Saha, P., Roberts, L.N., Arya, R., Changing paradigms in the management of deep vein thrombosis. Br J Haematol 170 (2015), 162–174.
29. 29 Rabinovich, A., Cohen, J.M., Cushman, M., Wells, P.S., Rodger, M.A., Kovacs, M.J., et al. Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post-thrombotic syndrome. J Thromb Haemost 13 (2015), 398–408.
30. 30 Roumen-Klappe, E.M., Janssen, M.C., Van Rossum, J., Holewijn, S., Van Bokhoven, M.M., Kaasjager, K., et al. Inflammation in deep vein thrombosis and the development of post-thrombotic syndrome: a prospective study. J Thromb Haemost 7 (2009), 582–587.
31. 31 Rabinovich, A., Cohen, J.M., Kahn, S.R., The predictive value of markers of fibrinolysis and endothelial dysfunction in the post thrombotic syndrome. A systematic review. Thromb Haemost 111 (2014), 1031–1040.